Skip to content

To compare the effectiveness of Lidocaine-Prilocaine cream and lignocaine infiltration during episiotomy repair.

Comparison of the Effects of Lidocaine -Prilocaine Cream and Lidocaine injection for pain relief during perineal repair following Vaginal Delivery â?? A Randomized Clinical Trial â??

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036668
Enrollment
242
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Lidocaine-Prilocaine Cream: Patient in intervention group will receive 5 gm each of lidocaine-prilocaine cream at 8- 9 cm dilatation and after giving episiotomy Control Intervention1: L

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All antenatal females presenting to the labor room for vaginal delivery and : 1. Period of gestational age > 37 weeks 2. Singleton pregnancy 3. Cephalic presentation

Exclusion criteria

Exclusion criteria: 1. Patients opting for epidural analgesia 2. Cervical tears 3. Any contraindications to use of any of these drugs 4. Known skin allergies

Design outcomes

Primary

MeasureTime frame
To compare the effects of lidocaine prilocaine cream and lidocaine injection for pain relief during perineal repair following vaginal birthTimepoint: 2 hours after delivery

Secondary

MeasureTime frame
1. To study the satisfaction level of patient with lidocaine prilocaine cream ( EMLA cream) and lidocaine injection use during perineal repair following vaginal birth. 2. To compare the ease of use of lidocaine prilocaine cream (EMLA cream) and lidocaine injection use during perineal repair following vaginal birth by the obstetrician. 3. To compare the requirement of extra analgesia in both the groups. 4. To study the side effects of both the drug in the study population.Timepoint: 2 hours to 3 days

Countries

India

Contacts

Public ContactDr Pratibha Singh

AIIMS Jodhpur

drpratibha69@hotmail.com8003996941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026